News Welcure Drugs & Pharmaceuticals Limited

Equities

WELCURE6

INE331C01017

Market Closed - Bombay S.E. Other stock markets 06:00:53 2024-05-06 am EDT			5-day change	1st Jan Change
4.74 ^INR	+3.72%		-2.67%	+23.12%

Mar. 22	Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024	CI
Feb. 16	Welcure Drugs & Pharmaceuticals Appoints Managing Director, CFO	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024	Mar. 22	CI
Welcure Drugs & Pharmaceuticals Appoints Managing Director, CFO	Feb. 15	MT
Welcure Drugs & Pharmaceuticals Limited Announces Board Resignations	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Vishal Mehra as Chief Financial Officer	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mr. Vishal Mehra as Managing Director	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Approves Executive Changes	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Managing Director	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Chief Financial Officer	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Welcure Drugs & Pharmaceuticals Limited Approves the Shifting of the Registered Office	Feb. 14	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14	CI
Welcure Drugs & Pharmaceuticals Limited Announces Change of Address	Nov. 14	CI
Welcure Drugs & Pharmaceuticals Limited Approves Board Changes	Nov. 14	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mayank Bhandari as Non Executive and Independent Director	23-10-30	CI
Welcure Drugs & Pharmaceuticals Limited Announces Executive Changes	23-09-30	CI
Welcure Drugs & Pharmaceuticals Limited Approves Shifting of Registered Office Within the Local Limits of City of Delhi	23-09-04	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-07-11	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-10-08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mitashi Bisaria as Company Secretary / Compliance Officer, Effective October 8, 2022	22-10-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Welcure Drugs & Pharmaceuticals Limited

Equities

WELCURE6

INE331C01017

Summary

Filters